- Home
- MDGL vs GLBE Comparison
MDGL vs GLBE Comparison
Compare MDGL & GLBE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- GLBE
- Stock Information
- Founded
- MDGL 2011
- GLBE 2013
- Country
- MDGL United States
- GLBE Israel
- Employees
- MDGL N/A
- GLBE N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- GLBE Computer Software: Prepackaged Software
- Sector
- MDGL Health Care
- GLBE Technology
- Exchange
- MDGL Nasdaq
- GLBE Nasdaq
- Market Cap
- MDGL 6.8B
- GLBE 6.1B
- IPO Year
- MDGL N/A
- GLBE 2021
- Fundamental
- Price
- MDGL $282.86
- GLBE $34.28
- Analyst Decision
- MDGL Strong Buy
- GLBE Strong Buy
- Analyst Count
- MDGL 10
- GLBE 13
- Target Price
- MDGL $420.63
- GLBE $51.69
- AVG Volume (30 Days)
- MDGL 382.7K
- GLBE 1.8M
- Earning Date
- MDGL 05-01-2025
- GLBE 05-14-2025
- Dividend Yield
- MDGL N/A
- GLBE N/A
- EPS Growth
- MDGL N/A
- GLBE N/A
- EPS
- MDGL N/A
- GLBE N/A
- Revenue
- MDGL $317,383,000.00
- GLBE $796,773,000.00
- Revenue This Year
- MDGL $264.55
- GLBE $26.20
- Revenue Next Year
- MDGL $67.21
- GLBE $24.94
- P/E Ratio
- MDGL N/A
- GLBE N/A
- Revenue Growth
- MDGL N/A
- GLBE 33.20
- 52 Week Low
- MDGL $200.08
- GLBE $26.64
- 52 Week High
- MDGL $377.46
- GLBE $63.69
- Technical
- Relative Strength Index (RSI)
- MDGL 35.76
- GLBE 43.66
- Support Level
- MDGL $287.46
- GLBE $35.68
- Resistance Level
- MDGL $307.54
- GLBE $43.21
- Average True Range (ATR)
- MDGL 16.58
- GLBE 1.38
- MACD
- MDGL -2.70
- GLBE 0.42
- Stochastic Oscillator
- MDGL 3.19
- GLBE 13.22
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.
About GLBE Global-E Online Ltd.
Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from and anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.